12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, several healthcare stocks experienced significant movements. MSP Recovery (LIFW) led the gainers with a 23.1% rise, while Aethlon Medical (AEMD) saw the largest decline among the losers, dropping 20.9%. Other notable movers included 60 Degrees (SXTP), Telesis Bio (TBIO), scPharmaceuticals (SCPH), and OpGen (OPGN) with substantial gains, and XBiotech (XBIT), NexImmune (NEXI), Bionomics (BNOX), Senti Biosciences (SNTI), and Celularity (CELU) with notable losses.
January 22, 2024 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aethlon Medical (AEMD) stock declined by 20.9% to $1.5, with a market cap of $3.7 million.
The substantial pre-market decline in AEMD's stock price could reflect negative investor sentiment, likely leading to a short-term downward trend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
MSP Recovery (LIFW) shares rose 23.1% to $1.49, with a market cap of $21.4 million.
The significant pre-market rise in LIFW's stock price suggests positive investor sentiment which could lead to a short-term upward trend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
OpGen (OPGN) shares increased by 16.32% to $0.29, with a market cap of $2.9 million.
OPGN's pre-market increase may indicate growing investor confidence, potentially leading to a short-term uptick in its stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
scPharmaceuticals (SCPH) stock increased by 16.47% to $6.22, with a market cap of $223.0 million.
The significant rise in SCPH's stock price during pre-market trading could suggest a positive short-term trajectory for the stock.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
60 Degrees (SXTP) stock moved upwards by 19.8% to $0.75, with a market cap of $4.3 million.
The notable increase in SXTP's stock price may attract investor attention and could result in a positive short-term price movement.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Telesis Bio (TBIO) shares moved upwards by 17.61% to $0.37, with a market cap of $11.1 million.
TBIO's pre-market gain indicates a positive investor outlook, which could lead to further short-term appreciation in stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90